21.07.2014
- In its fifth attempt to buy the company, AbbVie, a recent spin-off of US drugmaker Abbott Laboratories, has won the race to acquire European rival Shire, clinching the deal for...
15.07.2014
- Dublin-based pharmaceutical producer Shire, a specialist in drugs to treat rare diseases, has succumbed to an increased £31 billion ($53 billion) takeover offer from US drugmaker...
09.07.2014
- US drugmaker AbbVie has raised its offer for London-based pharmaceutical producer Shire to £30.1 billion ($51.3 billion), hoping to win over its reluctant target after three...
24.06.2014
- British drugmaker Shire has rejected a £27 billion ($46 billion) takeover offer from AbbVie, the latest attempt by a US healthcare firm to tap into lower tax rates abroad via an...
07.02.2014
- Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...
22.10.2013
- Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug...
30.07.2013
- Expectations that Bayer will embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve. The diversified German healthcare group has an...
24.07.2013
- A U.S. Supreme Court ruling giving regulators the right to sue drugmakers for agreements that delay sale of cheaper generic pharmaceuticals should deter some of the most egregious...
